Related Experiment Videos
Aberrant splicing induced by missense mutations in BRCA1: clues from a humanized mouse model
Yongping Yang1, Srividya Swaminathan, Betty K Martin
1Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute at Frederick, 1050 Boyles Street, Frederick, MD 21702, USA.
Human Molecular Genetics
|August 14, 2003
Summary
Missense mutations in the BRCA1 gene can cause breast cancer. This study reveals how one mutation leads to a non-functional protein by disrupting RNA splicing, highlighting the need for careful analysis of genetic alterations.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Missense mutations in the human BRCA1 gene are associated with breast cancer predisposition.
- The functional impact of most BRCA1 mutations remains largely uncharacterized.
Purpose of the Study:
- To investigate the molecular mechanisms underlying three cancer-associated BRCA1 missense mutations.
- To determine the functional consequences of specific BRCA1 gene alterations.
Main Methods:
- Utilized a humanized mouse model to study a T-to-G transversion at codon 64 in the BRCA1 gene.
- Employed the Genscan program to screen for other missense mutations potentially causing aberrant splicing.
Main Results:
- A T-to-G transversion at codon 64 in BRCA1 resulted in a functionally null protein due to aberrant splicing.
- This mutation created a new splice site and disrupted an enhancer, leading to a 22-nucleotide deletion and a truncated protein.
- Identified at least two additional BRCA1 missense mutations (codons 1495 and 1823) that likely cause aberrant splicing.
Conclusions:
- Demonstrated the utility of a humanized mouse model for functional analysis of human mutations.
- Emphasized the critical need to evaluate the functional impact of single base alterations and SNPs in disease-associated genes like BRCA1.